ACM
PFE icon

AlphaStar Capital Management’s Pfizer PFE Stock Holding History

AlphaStar Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-140,452
Closed -$3.4M – 312
2025
Q2 		$3.4M Buy
+140,452
New +$3.28M 0.24% 74
2024
Q2 		– Sell
-16,945
Closed -$470K – 322
2024
Q1 		$470K Buy
16,945
+128
+0.8% +$3.55K 0.05% 182
2023
Q4 		$968K Buy
+16,817
New +$508K 0.09% 116
2023
Q3 		– Sell
-7,299
Closed -$268K – 264
2023
Q2 		$268K Sell
7,299
-1,587
-18% -$61.8K 0.03% 232
2023
Q1 		$364K Sell
8,886
-36,038
-80% -$1.56M 0.03% 211
2022
Q4 		$2.29M Sell
44,924
-2,186
-5% -$105K 0.24% 82
2022
Q3 		$2.06M Sell
47,110
-14,990
-24% -$728K 0.22% 86
2022
Q2 		$3.26M Sell
62,100
-20,349
-25% -$1.04M 0.3% 65
2022
Q1 		$4.27M Sell
82,449
-16,070
-16% -$834K 0.34% 58
2021
Q4 		$5.41M Buy
98,519
+4,512
+5% +$224K 0.43% 50
2021
Q3 		$4.03M Buy
94,007
+81,668
+662% +$3.62M 0.27% 77
2021
Q2 		$493K Buy
12,339
+5,757
+87% +$224K 0.06% 188
2021
Q1 		$238K Sell
6,582
-20,769
-76% -$737K 0.04% 203
2020
Q4 		$1M Buy
27,351
+11,616
+74% +$426K 0.17% 98
2020
Q3 		$564K Buy
15,735
+1,405
+10% +$49.3K 0.11% 117
2020
Q2 		$486K Buy
14,330
+731
+5% +$24.8K 0.1% 118
2020
Q1 		$460K Sell
13,599
-3,018
-18% -$103K 0.11% 121
2019
Q4 		$618K Buy
16,617
+151
+0.9% +$5.38K 0.13% 110
2019
Q3 		$561K Sell
16,466
-3,038
-16% -$110K 0.13% 112
2019
Q2 		$802K Sell
19,504
-2,788
-13% -$111K 0.2% 88
2019
Q1 		$898K Sell
22,292
-1,080
-5% -$43.3K 0.25% 68
2018
Q4 		$968K Sell
23,372
-1,634
-7% -$67.8K 0.31% 70
2018
Q3 		$1.05M Sell
25,006
-3,334
-12% -$128K 0.31% 73
2018
Q2 		$975K Buy
28,340
+13,927
+97% +$476K 0.31% 76
2018
Q1 		$485K Buy
+14,413
New +$495K 0.18% 102
2017
Q4 		– Sell
-5,951
Closed -$202K – 210
2017
Q3 		$202K Buy
+5,951
New +$191K 0.2% 92

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AlphaStar Capital Management's PFE Position: Q3 2025 in Review

AlphaStar Capital Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 140,452 shares — an estimated $3.4M sold.

AlphaStar Capital Management first reported a position in PFE in Q3 2017 and held it in 26 quarters. The position peaked at $5.41M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • AlphaStar Capital Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • AlphaStar Capital Management sold 140,452 Pfizer shares in Q3 2025, an estimated $3.4M.
  • AlphaStar Capital Management first reported a position in Pfizer in Q3 2017 and held it in 26 quarters.
  • AlphaStar Capital Management's Pfizer position peaked at $5.41M in Q4 2021.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on AlphaStar Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.